• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对冠状动脉疾病发病机制及预防的见解

Insights into the pathogenesis and prevention of coronary artery disease.

作者信息

O'Keefe J H, Lavie C J, McCallister B D

机构信息

Mid America Heart Institute, Kansas City, Missouri.

出版信息

Mayo Clin Proc. 1995 Jan;70(1):69-79. doi: 10.1016/S0025-6196(11)64669-7.

DOI:10.1016/S0025-6196(11)64669-7
PMID:7808056
Abstract

OBJECTIVE

To present information about risk factor clustering and the oxidation hypothesis of atherosclerosis and attempt to synthesize these facts into a clinically relevant approach to patients with or at risk for coronary artery disease (CAD).

MATERIAL AND METHODS

The total cholesterol level is a relatively weak marker for the risk of CAD. The levels of both high-density lipoprotein (HDL) cholesterol and remnants of triglyceride-rich lipoproteins and the inherent susceptibility of the low-density lipoprotein (LDL) particles to oxidative modification may be as important as the total or LDL cholesterol levels. LDL cholesterol must undergo oxidative modification by means of oxygen free radical processes before it becomes atherogenic. Patients with high levels of oxidative stress include those with risk factor clustering or insulin resistance (or both). Such patients are characterized by hypertension, truncal obesity, hypertriglyceridemia, depressed HDL cholesterol levels, and increased insulin levels. They also have increased levels of triglyceride-rich remnant lipoproteins and LDL particles that are characterized by their small dense nature and pronounced predisposition to oxidative modification.

RESULTS

Biologic antioxidants seem to be promising therapy for the prevention of atherogenesis. Although long-term prospective data are not yet available, vitamin E has been shown to be effective in both animal and human models in preventing LDL oxidation, and it may have a role in the prevention of CAD. A healthy diet of fresh fruits, vegetables, and whole grains is beneficial because it improves the lipid levels and provides high levels of natural antioxidants. The atherogenic potential of hydrogenated polyunsaturated fats is approximately equivalent to that of saturated fats. Monounsaturated fat is inherently resistant to oxidation and may be protective against CAD. Niacin may be effective in patients with clustered risk factors. It has been found to convert the easily oxidized small dense LDL pattern to the large buoyant oxidation-resistant particles. Hydroxymethylglutaryl-coenzyme A reductase inhibitors are well tolerated and highly effective in decreasing LDL cholesterol, but they are expensive. Estrogen has multiple potentially beneficial effects relative to cardiovascular disease.

CONCLUSION

Persons with or at high risk for CAD should be identified early and aggressively treated with a program that involves lifestyle changes, alterations in dietary intake, and pharmacologic therapy.

摘要

目的

介绍有关危险因素聚集和动脉粥样硬化氧化假说的信息,并尝试将这些事实综合成一种针对患有冠状动脉疾病(CAD)或有CAD风险患者的临床相关方法。

材料与方法

总胆固醇水平是CAD风险的相对较弱标志物。高密度脂蛋白(HDL)胆固醇水平、富含甘油三酯脂蛋白残粒水平以及低密度脂蛋白(LDL)颗粒对氧化修饰的固有易感性可能与总胆固醇或LDL胆固醇水平同样重要。LDL胆固醇在具有致动脉粥样硬化性之前必须通过氧自由基过程进行氧化修饰。氧化应激水平高的患者包括那些具有危险因素聚集或胰岛素抵抗(或两者兼有)的患者。这类患者的特征是高血压、躯干肥胖、高甘油三酯血症、HDL胆固醇水平降低以及胰岛素水平升高。他们还具有富含甘油三酯的残粒脂蛋白和LDL颗粒水平升高,这些颗粒的特征是小而致密,且极易发生氧化修饰。

结果

生物抗氧化剂似乎是预防动脉粥样硬化的有前景的疗法。尽管尚无长期前瞻性数据,但维生素E已在动物和人体模型中均显示出在预防LDL氧化方面有效,并且它可能在预防CAD中发挥作用。富含新鲜水果、蔬菜和全谷物的健康饮食有益,因为它可改善血脂水平并提供高水平的天然抗氧化剂。氢化多不饱和脂肪的致动脉粥样硬化潜力与饱和脂肪大致相当。单不饱和脂肪固有地抗氧化,可能对CAD有保护作用。烟酸可能对具有聚集危险因素的患者有效。已发现它可将易于氧化的小而致密的LDL模式转变为大的、有浮力的抗氧化颗粒。羟甲基戊二酰辅酶A还原酶抑制剂耐受性良好,在降低LDL胆固醇方面非常有效,但价格昂贵。雌激素相对于心血管疾病具有多种潜在有益作用。

结论

应尽早识别出患有CAD或有高CAD风险的人群,并积极采用包括生活方式改变、饮食摄入调整和药物治疗的方案进行治疗。

相似文献

1
Insights into the pathogenesis and prevention of coronary artery disease.对冠状动脉疾病发病机制及预防的见解
Mayo Clin Proc. 1995 Jan;70(1):69-79. doi: 10.1016/S0025-6196(11)64669-7.
2
Women, lipoproteins and cardiovascular disease risk.女性、脂蛋白与心血管疾病风险
Can J Cardiol. 1990 May;6 Suppl B:23B-29B.
3
Pharmacologic treatment of type 2 diabetic dyslipidemia.2型糖尿病血脂异常的药物治疗。
Pharmacotherapy. 2004 Dec;24(12):1692-713. doi: 10.1592/phco.24.17.1692.52340.
4
Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.通过升高高密度脂蛋白胆固醇降低心血管风险:烟酸的作用——欧洲高密度脂蛋白胆固醇共识小组制定的立场文件
Curr Med Res Opin. 2004 Aug;20(8):1253-68. doi: 10.1185/030079904125004402.
5
Lipids as a coronary risk factor: analysis of hyperlipidaemias.脂质作为冠状动脉危险因素:高脂血症分析
Postgrad Med J. 1993;69 Suppl 1:S8-11.
6
Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes.改变甘油三酯和富含甘油三酯的脂蛋白对心血管结局的影响。
J Cardiovasc Pharmacol. 2008 Apr;51(4):331-51. doi: 10.1097/FJC.0b013e318165e2e7.
7
The role of dietary oxidized cholesterol and oxidized fatty acids in the development of atherosclerosis.膳食氧化胆固醇和氧化脂肪酸在动脉粥样硬化发展中的作用。
Mol Nutr Food Res. 2005 Nov;49(11):1075-82. doi: 10.1002/mnfr.200500063.
8
Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches.致动脉粥样硬化的致密低密度脂蛋白。病理生理学与新治疗方法。
Eur Heart J. 1998 Feb;19 Suppl A:A24-30.
9
[Modified low-density lipoprotein].[修饰的低密度脂蛋白]
Nihon Rinsho. 1994 Dec;52(12):3090-5.
10
Diet, lipids, and coronary heart disease.饮食、脂质与冠心病
Endocrinol Metab Clin North Am. 1990 Jun;19(2):321-44.

引用本文的文献

1
Tocopherols in the Prevention and Treatment of Atherosclerosis and Related Cardiovascular Disease.生育酚在动脉粥样硬化及相关心血管疾病防治中的应用
Clin Cardiol. 2015 Sep;38(9):570-6. doi: 10.1002/clc.22422. Epub 2015 Aug 14.
2
Effect of low calorie diet with rice bran oil on cardiovascular risk factors in hyperlipidemic patients.米糠油低热量饮食对高脂血症患者心血管危险因素的影响。
J Res Med Sci. 2012 Jul;17(7):626-31.
3
Cardiac rehabilitation, exercise training, and preventive cardiology research at Ochsner Heart and Vascular Institute.
奥施纳心脏与血管研究所的心脏康复、运动训练及预防心脏病学研究。
Tex Heart Inst J. 1995;22(1):44-52.